Clinical Trials Browser

Phase 2/3 × Diabetes Mellitus, Type 2 × dapagliflozin × Clear all

NCT07033585 2025-07-11

GD-T2D

Phase 2/3 Active not recruiting

Diabetes Mellitus, Diabetes Mellitus, Type 2